UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry

Journal of the American Heart Association, 2019-04, Vol.8 (7), p.e011765

2019

Volltextzugriff (PDF)

Efficacy and safety of alirocumab in patients with or without prior coronary revascularization: Pooled analysis of eight ODYSSEY phase 3 trials

Atherosclerosis, 2018-10, Vol.277, p.211-218

2018

Volltextzugriff (PDF)

Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry

JAMA cardiology, 2018-08, Vol.3 (8), p.739

2018

Volltextzugriff (PDF)

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

Journal of the American Heart Association, 2018-05, Vol.7 (10), p.n/a

2018

Volltextzugriff (PDF)

Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry

Journal of the American Heart Association, 2018-09, Vol.7 (18), p.e009251-e009251

2018

Volltextzugriff (PDF)

Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials

Journal of the American Heart Association, 2018-09, Vol.7 (18), p.e009221

2018

Volltextzugriff (PDF)

Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry

The American heart journal, 2015-11, Vol.170 (5), p.865-871

2015

Volltextzugriff (PDF)

Peripheral arterial disease: current perspectives and new trends in management

Southern medical journal (Birmingham, Ala.), 2009-11, Vol.102 (11), p.1141-1149

2009

Volltextzugriff (PDF)

The Effect of Definity on Systemic and Pulmonary Hemodynamics in Patients

Journal of the American Society of Echocardiography, 2012-05, Vol.25 (5), p.584-588

2012

Volltextzugriff (PDF)

Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry

The American heart journal, 2017-11, Vol.193, p.84-92

2017

Volltextzugriff (PDF)

Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control

Atherosclerosis, 2019-09, Vol.288, p.85-93

2019

Volltextzugriff (PDF)

Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry

The American heart journal, 2018-06, Vol.200, p.118-124

2018

Volltextzugriff (PDF)

Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry)

The American journal of cardiology, 2019-04, Vol.123 (7), p.1011-1018

2019

Volltextzugriff (PDF)

TCT-586 Alirocumab efficacy and safety in patients with prior coronary revascularization

Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.B242-B243

2017

Volltextzugriff (PDF)

Hyperlipidemia in Older Adults

Clinics in geriatric medicine, 2009-11, Vol.25 (4), p.591-606

2009

Volltextzugriff (PDF)

Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials

Scientific reports, 2017-04, Vol.7 (1), p.45788-45788, Article 45788

2017

Volltextzugriff (PDF)

Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry

Circulation Cardiovascular quality and outcomes, 2018-03, Vol.11 (3), p.e004249-e004249

2018

Volltextzugriff (PDF)

Anticoagulants in Coronary Artery Disease

Cardiology clinics, 2008-11, Vol.26 (4), p.615-628

Lee, L. Veronica, MD

2008

Volltextzugriff (PDF)

CONTEMPORARY PATTERNS OF LIPID TESTING IN PRIMARY AND SECONDARY PREVENTION PATIENTS: INSIGHTS FROM THE PALM REGISTRY

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1695-1695

2017

Volltextzugriff (PDF)

Predictive factors for alirocumab dose increase in patients with heterozygous familial hypercholesterolaemia

Atherosclerosis, 2017-08, Vol.263, p.e243-e243

2017

Volltextzugriff (PDF)

Abstract 17099: Additional LDL-C Reduction Achieved With Alirocumab Dose Increase on Background Statin

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A17099-A17099

2015

Volltextzugriff (PDF)

Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia

Coronary artery disease, 2017-05, Vol.28 (3), p.190-197

2017

Volltextzugriff (PDF)

PREVALENCE AND MANAGEMENT OF PATIENT-REPORTED SYMPTOMS ON STATIN THERAPY: INSIGHTS FROM THE PATIENT AND PROVIDER ASSESSMENT OF LIPID MANAGEMENT (PALM) REGISTRY

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1894-1894

2016

Volltextzugriff (PDF)

PATIENTS’ PERCEIVED VERSUS PREDICTED CARDIOVASCULAR DISEASE RISK: CHALLENGES FOR SHARED DECISION-MAKING IN CHOLESTEROL MANAGEMENT

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1929-1929

2016

Volltextzugriff (PDF)

Abstract 17279: Have the 2013 AHA/ACC Cholesterol Guidelines Affected Clinicians’ Lipid Management Strategies?

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A17279-A17279

2015

Volltextzugriff (PDF)

1 – 25 von 425

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(401)
Mit Volltextzugriff
(345)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry

Efficacy and safety of alirocumab in patients with or without prior coronary revascularization: Pooled analysis of eight ODYSSEY phase 3 trials

Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry

Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials

Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry

Peripheral arterial disease: current perspectives and new trends in management

The Effect of Definity on Systemic and Pulmonary Hemodynamics in Patients

Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry

Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control

Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry

Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry)

TCT-586 Alirocumab efficacy and safety in patients with prior coronary revascularization

Hyperlipidemia in Older Adults

Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials

Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry

Anticoagulants in Coronary Artery Disease

CONTEMPORARY PATTERNS OF LIPID TESTING IN PRIMARY AND SECONDARY PREVENTION PATIENTS: INSIGHTS FROM THE PALM REGISTRY

Predictive factors for alirocumab dose increase in patients with heterozygous familial hypercholesterolaemia

Abstract 17099: Additional LDL-C Reduction Achieved With Alirocumab Dose Increase on Background Statin

Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia

PREVALENCE AND MANAGEMENT OF PATIENT-REPORTED SYMPTOMS ON STATIN THERAPY: INSIGHTS FROM THE PATIENT AND PROVIDER ASSESSMENT OF LIPID MANAGEMENT (PALM) REGISTRY

PATIENTS’ PERCEIVED VERSUS PREDICTED CARDIOVASCULAR DISEASE RISK: CHALLENGES FOR SHARED DECISION-MAKING IN CHOLESTEROL MANAGEMENT

Abstract 17279: Have the 2013 AHA/ACC Cholesterol Guidelines Affected Clinicians’ Lipid Management Strategies?

Suchergebnisse filtern